Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ELVN
ELVN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ELVN News
Enliven Therapeutics Director Sells Shares Amid Rising Investor Sentiment
Jun 27 2026
NASDAQ.COM
Enliven Therapeutics Director Sells Shares
Jun 27 2026
Fool
Enliven Therapeutics Director Sells 10,000 Shares Amid 130% Stock Surge
Jun 27 2026
Yahoo Finance
Orbimed Advisors Sells 860,123 Shares of Enliven Therapeutics
Jun 27 2026
Fool
Orbimed Advisors Sells ELVN Shares Worth $39 Million
Jun 27 2026
NASDAQ.COM
Orbimed Advisors Reduces Stake in Enliven Therapeutics
Jun 24 2026
Fool
Orbimed Advisors Sells Shares in Enliven Therapeutics
Jun 24 2026
NASDAQ.COM
Enliven Therapeutics Closes $460 Million Upsized Public Offering
Jun 15 2026
Newsfilter
Enliven Therapeutics Closes $460 Million Upsized Public Offering
Jun 15 2026
PRnewswire
Biotech Company Movements Analysis
Jun 15 2026
NASDAQ.COM
Enliven Therapeutics Announces Key Trial Alignment and Public Offering
Jun 12 2026
stocktwits
Enliven Therapeutics Upsizes Public Offering to $400 Million
Jun 12 2026
seekingalpha
Enliven Therapeutics Completes Upsized Public Offering
Jun 12 2026
PRnewswire
Enliven Therapeutics Prices Upsized Public Offering
Jun 12 2026
Newsfilter
Enliven Therapeutics Launches $250 Million Public Offering
Jun 11 2026
seekingalpha
Enliven Therapeutics Reports Significant Phase 1 Trial Results for ELVN-001
Jun 11 2026
seekingalpha
Show More News
